About this episode

This episode discusses the role of autologous stem cell transplant in multiple myeloma with expert hematologists.

Throughout this series, we have discussed that for eligible patients, the current standard of care is to take patients for autologous stem cell transplant as consolidation for their multiple myeloma. In this reboot episode, we sit down with two incredible hematologists who specialize in transplant to discuss the real-life decision-making that goes into evaluating each patient. We are so excited to welcome two special guests this week, Dr. Shonali Midha and Dr. Amar Kelkar, joining us from the Dana-Farber Cancer Institute in Boston! Content: - What goes into determining if a patient is transplant eligible? - What counseling is provided to patients? - Approach to melphalan dosing - How does apheresis work? - What agents are used to help mobilize stem cells? - How many stem cells do we need to collect? - Does how much therapy one has received affect their collection? - Is there still a role for transplant in today's world? - Is there a role for an "MRD-adapted" approach to treatment? - Is there a role for a second transplant in patients who have relapsed? - Is there a role for allogeneic stem cell transplants in myeloma? A huge THANK YOU to our guests, Dr. Shonali Midha and Dr. Amar…

People in this episode

Host: Rouleaux University Medical Center

Guests: Dr. Shonali Midha, Dr. Amar Kelkar

Topics covered

• multiple myeloma
• stem cell transplant
• hematology
• patient eligibility
• treatment approaches

Keywords

• myeloma
• transplant
• stem cell
• melphalan
• apheresis
• MRD-adapted
• relapsed
• allogeneic

Mentioned in this episode

Organizations: Dana-Farber Cancer Institute

More episodes of The Fellow on Call: The Heme/Onc Podcast

• Episode 157: Immune Thrombocytopenic Purpura Series, Pt 3- Challenging Scenarios in ITP · July 1, 2026
• Episode 156: Immune Thrombocytopenic Purpura Series, Pt 2- Relapsed/Refractory · June 24, 2026
• Episode 155: Immune Thrombocytopenic Purpura Series, Pt 1- First Line Management · June 17, 2026
• Episode 154: Ask The Program Directors-The Do’s and Don'ts of Applying to Hematology Fellowship (Career Development Series) · May 20, 2026
• Episode 153: Myeloma Capstone, Pt 2 - MRD-Guided Therapy, Maintenance, and Relapsed/Refractory Sequencing · April 22, 2026
• Episode 152: Myeloma Capstone, Pt 1 - Smoldering Myeloma & Frontline Treatment in the Elderly · April 15, 2026

Explore listener stats, chart rankings, contacts and more on the The Fellow on Call: The Heme/Onc Podcast podcast page.